Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000400 USD | -20.00% |
|
-20.00% | -84.62% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 58.13M 54.33M 49.66M 93.58M 6.4B 95.04M 637M 250M 3.2B 252M 247M 10.67B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 131M 123M 112M 211M 14.47B 215M 1.44B 565M 7.24B 570M 557M 24.1B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -20.00% | ||
| 1 week | -20.00% | ||
| Current month | -20.00% | ||
| 1 month | -42.86% | ||
| 3 months | -55.56% | ||
| 6 months | -69.23% | ||
| Current year | -84.62% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.1 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 9.63 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 2011-03-31 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 2022-02-28 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 2017-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.00% | -20.00% | -73.33% | -99.76% | 217K | |
| +4.21% | +25.56% | +77.96% | +104.49% | 70.85B | |
| +0.50% | +6.20% | +34.94% | +67.83% | 55.41B | |
| +2.78% | +36.87% | +23.00% | +493.09% | 29.43B | |
| +0.87% | +18.87% | +57.08% | +5.18% | 24.12B | |
| -0.93% | +0.60% | -16.89% | -12.00% | 23.31B | |
| -0.35% | +7.91% | +44.14% | -22.61% | 18.37B | |
| +0.19% | +10.84% | +31.14% | +628.97% | 16.1B | |
| +7.26% | +14.16% | +221.03% | +393.89% | 16.99B | |
| -2.05% | -3.81% | +40.40% | +150.40% | 13.12B | |
| Average | -1.00% | +5.80% | +43.95% | +170.95% | 26.77B | |
| Weighted average by Cap. | +1.71% | +11.59% | +54.98% | +163.96% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 45.8M 42.81M 39.12M 73.73M 5.05B 74.88M 502M 197M 2.52B 199M 194M 8.41B | 62.84M 54.4M 50.85M 46.47M 87.57M 5.99B 88.94M 596M 234M 3B 236M 231M 9.99B |
| Net income | -428M -371M -347M -317M -597M -40.85B -606M -4.06B -1.59B -20.44B -1.61B -1.57B -68.07B | -573M -496M -464M -424M -798M -54.63B -811M -5.44B -2.13B -27.33B -2.15B -2.1B -91.03B |
| Net Debt | 111M 95.83M 89.57M 81.86M 154M 10.56B 157M 1.05B 412M 5.28B 416M 407M 17.59B | 84.53M 73.17M 68.4M 62.51M 118M 8.06B 120M 802M 315M 4.03B 317M 310M 13.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-10 | US$0.000400 | -20.00% | 94,560 |
| 26-08-07 | US$0.000500 | 0.00% | 80,587 |
| 26-08-06 | US$0.000500 | -16.67% | 31,830 |
| 26-08-05 | US$0.000600 | 0.00% | 27,562 |
| 26-08-04 | US$0.000600 | +20.00% | 164,469 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
